Figitumumab
Product Specifications
UNSPSC Description
Figitumumab (CP-751871) is a potent and fully human monoclonal anti–insulin-like growth factor 1 receptor (IGF1R) antibody. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM[1].
Target Antigen
IGF-1R
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/figitumumab.html
Purity
96.89
Solubility
10 mM in DMSO
Smiles
[Figitumumab]
References & Citations
[1]Pavlicek A, et al. Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871). Mol Cancer Ther. 2013 Dec;12(12):2929-39.|[2]Cohen BD, et al. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871. Clin Cancer Res. 2005 Mar 1;11(5):2063-73.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99197/Figitumumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99197/Figitumumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
943453-46-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1109216-01 0.02 mg (E-Coli)
Recombinant Azotobacter vinelandii Indole-3-glycerol phosphate synthase (trpC)
Ask
View Details MBS1109216-02 0.02 mg (Yeast)
Recombinant Azotobacter vinelandii Indole-3-glycerol phosphate synthase (trpC)
Ask
View Details MBS1109216-03 0.1 mg (E-Coli)
Recombinant Azotobacter vinelandii Indole-3-glycerol phosphate synthase (trpC)
Ask
View Details